Litcius/Paper detail

Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study

Abby S. Van Voorhees, Linda Stein Gold, Mark Lebwohl, Bruce Strober, Charles Lynde, Stephen K. Tyring, Ashley Cauthen, Howard Sofen, Zuoshun Zhang, Maria Paris, Yao Wang

2020Journal of the American Academy of Dermatology70 citationsDOI

Topics & Concepts

MedicineApremilastScalpPlaceboDermatologyMulticenter studyDouble blindPsoriasisRandomized controlled trialAdverse effectMulticenter trialSurgeryInternal medicinePathologyAlternative medicinePsoriatic arthritisPsoriasis: Treatment and PathogenesisSpondyloarthritis Studies and TreatmentsDermatology and Skin Diseases